| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |